Rational development of molecularly imprinted nanoparticles for blocking PD-1/PD-L1 axis
Sign Up to like & getrecommendations! Published in 2022 at "Chemical Science"
DOI: 10.1039/d2sc03412c
Abstract: Blocking the PD-1/PD-L1 immune checkpoint has emerged as a promising strategy in cancer immunotherapy, in which monoclonal antibodies are predominately used as inhibitors. Despite their remarkable success, monoclonal antibody-based therapeutics suffer from drawbacks due to… read more here.
Keywords: blocking axis; development molecularly; molecularly imprinted; rational development ... See more keywords